|
 |
|
|
|
Premier Research Group Limited, the international pharmaceutical services group, announces the appointment of Fabio Trave, MD as Executive Director of Medical Affairs and Strategic Product Development. In this position, Dr. Trave will expand Premier Research’s capabilities in the area of drug development consulting and strengthen capabilities in the oncology therapeutic area. Dr. Trave also brings to the organization significant expertise in the area of risk management and pharmacovigilance. Dr. Trave will be based in our Milan office.
Dr. Trave has extensive experience working for both North American and European-based pharmaceutical companies, including Farmitalia Carlo Erba, Warner Lambert Parke-Davis, Pharmacia Corporation, and Bristol Myers Squibb, where he was most recently responsible for pharmacovigilance activities in Europe, Middle East, and Africa. He received his medical degree from the University of Milan School of Medicine and completed his post-graduate training in Clinical Oncology at the Italian National Cancer Institute in Genoa and Experimental Therapeutics at Roswell Park Memorial Institute in Buffalo, NY.
”We are very pleased to have Dr. Trave join our Medical Affairs team of therapeutic experts,” commented Dr. Samer Kaba, Vice President of Global Medical Affairs and SPD. “His global perspective and diverse expertise will strengthen our department and help us to expand our drug development and risk management consulting services to meet the evolving needs of our clients.” |
|
|
 |
|